1-7 of 7
Liana Adam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway

Free
Liana Adam, F. Anthony San Lucas, Richard Fowler, Yao Yu, Wenhui Wu, Yulun Liu, Huamin Wang, David Menter, Michael T. Tetzlaff, Joe Ensor, Jr, Ganiraju Manyam, Stefan T. Arold, Chad Huff, Scott Kopetz, Paul Scheet, Michael J. Overman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (2): 641–651.
https://doi.org/10.1158/1078-0432.CCR-18-1480
Published: 15 January 2019
View articletitled, DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Open the PDF for DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway in another window
Includes: Supplementary data
Journal Articles

Systemic microRNA measurement, a useful tool for intelligent clinical decision support systems in bladder cancer

Free
Sulaimon Ajibode, Liu Chang-Gong, Jitao David Zhang, Alexander Zien, Diao Lixia, Wang Jing, Traila Nicola, David Jackson, Colin Dinney, Liana Adam
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): A19.
https://doi.org/10.1158/DIAG-10-A19
Published: 15 August 2014
View articletitled, Systemic microRNA measurement, a useful tool for intelligent clinical decision support systems in bladder cancer
Journal Articles

miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

Free
Liana Adam, Meng Zhong, Woonyoung Choi, Wei Qi, Milena Nicoloso, Ameeta Arora, George Calin, Hua Wang, Arlene Siefker-Radtke, David McConkey, Menashe Bar-Eli, Colin Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5060–5072.
https://doi.org/10.1158/1078-0432.CCR-08-2245
Published: 12 August 2009
View articletitled, miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Open the PDF for miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy in another window
Includes: Supplementary data
Journal Articles

Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase

Free
Poonam R. Molli, Liana Adam, Rakesh Kumar
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6161–6170.
https://doi.org/10.1158/1078-0432.CCR-07-5288
Published: 30 September 2008
View articletitled, Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase
Open the PDF for Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase in another window
Journal Articles

Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells

Free
Peter C. Black, Gordon A. Brown, Teruo Inamoto, Marissa Shrader, Ameeta Arora, Arlene O. Siefker-Radtke, Liana Adam, Dan Theodorescu, Xifeng Wu, Mark F. Munsell, Menashe Bar-Eli, David J. McConkey, Colin P.N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1478–1486.
https://doi.org/10.1158/1078-0432.CCR-07-1593
Published: 03 March 2008
View articletitled, Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells
Open the PDF for Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells in another window
Journal Articles

Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy

Free
Kelly N. Blehm, Philippe E. Spiess, Jolanta E. Bondaruk, Melanie E. Dujka, Gabriel J. Villares, Yi-jue Zhao, Oliver Bogler, Kenneth D. Aldape, H. Barton Grossman, Liana Adam, David J. McConkey, Bogdan A. Czerniak, Colin P. Dinney, Menashe Bar-Eli
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4671–4677.
https://doi.org/10.1158/1078-0432.CCR-06-0407
Published: 09 August 2006
View articletitled, Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy
Open the PDF for Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy in another window
Journal Articles

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells

Free
Zhibo Yang, Rozita Bagheri-Yarmand, Rui-An Wang, Liana Adam, Vali Vassiliki Papadimitrakopoulou, Gary L. Clayman, Adel El-Naggar, Reuben Lotan, Christopher J. Barnes, Waun Ki Hong, Rakesh Kumar
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (2): 658–667.
https://doi.org/10.1158/1078-0432.CCR-0382-03
Published: 03 February 2004
View articletitled, The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells
Open the PDF for The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells in another window